Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3054
+0.0030 (0.99%)
At close: Dec 31, 2025, 4:00 PM EST
0.3082
+0.0028 (0.91%)
After-hours: Dec 31, 2025, 7:42 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $24.05 million as of December 31, 2025. Its market cap has decreased by -59.59% in one year.
Market Cap
24.05M
Enterprise Value
9.80M
1-Year Change
-59.59%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $24.05M, a decrease of -87.57%. That is a compound annual growth rate of -22.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 499.71B |
| AbbVie | 408.27B |
| UnitedHealth Group | 303.62B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.73B |
| Novo Nordisk | 229.27B |